Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Rectosigmoidoscopy vs. Colonoscopy for Assessing Ulcerative Colitis Activity

Reuters Health  |  October 30, 2015

Dr. Marietta Iacucci, a gastroenterologist from the University of Calgary, Alberta, Canada, told Reuters Health by email, “Physicians should initially do a full colonoscopy to assess the extent and severity of ulcerative colitis. Once the extent is known, often flexible sigmoidoscopy may be enough to determine response to treatment.”

“In ulcerative colitis patients, a flexible sigmoidoscopy may be sufficient to assess inflammation and response to therapy,” she explained. “This is easier on the patient, as they do not require a full bowel cleansing, and can be done most often without requiring any sedation. It is also a much shorter procedure, perhaps seven minutes at most compared with 30 minutes for a full colonoscopy.”

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Dr. Iacucci, who was not involved in the new research, added, “In patients who use topical rectal treatment, the rectum may heal but inflammation may remain further upstream in the colon. In these patients a full colonoscopy may be required to assess inflammation. In patients with left sided ulcerative colitis, the disease may extend in patients further upstream associated with a relapse. These patients may also require a colonoscopy, especially if their symptoms change. In patients with ulcerative colitis and primary sclerosing cholangitis, an inflammation of the bile ducts, the inflammation may be limited to the right colon and these patients may need a full colonoscopy to assess their symptoms. And finally, when a gastroenterologist wants to exclude a colon cancer, a full colonoscopy needs to be done.”

Page: 1 2 | Single Page
Share: 

Filed under:ConditionsOther Rheumatic Conditions Tagged with:etrolizumabrectosigmoidoscopyulcerative colitis

Related Articles

    Unexpected Benefits of Bisphosphonates after Hip Fracture

    February 3, 2012

    Recent trials show this bisphosphonates can reduce subsequent hip fractures and mortality, while remaining cost effective.

    Mucosal Healing Seen with Infliximab Biosimilar CT-P13 in Ulcerative Colitis

    May 3, 2016

    NEW YORK (Reuters Health)—About two-thirds of patients with ulcerative colitis (UC) had mucosal healing by the end of induction treatment with the infliximab biosimilar CT-P13, according to results of the first prospective study to evaluate this. CT-P13 is the first biosimilar monoclonal antibody of reference infliximab (Remicade) approved in Europe and several other countries where…

    Case Report: Possible Overlapping Vasculitis & Ulcerative Colitis

    January 17, 2020

    A 42-year-old man with a history of ulcerative colitis (UC), primary sclerosing cholangitis (PSC) and chronic sinusitis was referred to a rheumatologist to evaluate for a possible diagnosis of systemic vasculitis. This patient had developed new skin lesions, gingival hypertrophy and ulcerating tracheobronchitis, concerning for possible granulomatosis with polyangiitis (GPA). Since 1994, the patient had…

    Adalimumab, Tacrolimus Effective for Treating Refractory Ulcerative Colitis

    October 15, 2015

    NEW YORK (Reuters Health)—The human IgG1 anti-TNF antibody adalimumab is safe and effective for short- and long-term treatment, and the calcineurin inhibitor tacrolimus given short-term brings remission, in patients with refractory ulcerative colitis, according to two new studies in the Journal of Crohn’s and Colitis. In the first study, online Sept. 21, Dr. Tamas Molnar…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences